TABLE 2.
Group | n | TT | TC | T | C |
---|---|---|---|---|---|
Patients | 350 | 332 (94.9) | 18 (5.1) | 682 (97.4) | 18 (2.6) |
Controls | 300 | 289 (96.3) | 11 (3.7) | 589 (98.2) | 11 (1.8) |
χ2 | 0.826 | 0.880 | |||
p | 0.363 | 0.348 |
Group | n | TT | TC | T | C |
---|---|---|---|---|---|
Patients | 350 | 332 (94.9) | 18 (5.1) | 682 (97.4) | 18 (2.6) |
Controls | 300 | 289 (96.3) | 11 (3.7) | 589 (98.2) | 11 (1.8) |
χ2 | 0.826 | 0.880 | |||
p | 0.363 | 0.348 |